Analyst Ratings for 9 Meter Biopharma (NMTR)

NMTR Rating Summary

  |   Expand Research on NMTR
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/26/2023 Brookline Capital Markets Kemp Dolliver Downgrade Hold
(Buy)		 N/A
(N/A)		 0.78
(0.07)		 -91.03% Details
3/20/2023 Truist Securities Srikripa Devarakonda Downgrade Hold
(Buy)		 N/A
(N/A)		 1.41
(0.07)		 -95.04% Details